> top > docs > PMC:7408073 > spans > 35872-36245 > annotations

PMC:7408073 / 35872-36245 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1423 162-170 Gene denotes Ang-(1–7 Gene:284
1424 250-254 Gene denotes ACE2 Gene:59272
1425 354-358 Gene denotes ACE2 Gene:59272
1435 188-196 Gene denotes Ang (1–5 Gene:284
1440 277-281 Gene denotes MasR Gene:116511
1441 104-108 Gene denotes MasR Gene:116511
1442 25-29 Gene denotes MasR Gene:116511
1460 359-372 Disease denotes hyperactivity MESH:D006948

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T419 39-42 http://purl.obolibrary.org/obo/CLO_0051582 denotes has

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T318 162-165 Chemical denotes Ang http://purl.obolibrary.org/obo/CHEBI_48433
T319 188-191 Chemical denotes Ang http://purl.obolibrary.org/obo/CHEBI_48433
T320 265-275 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T321 282-293 Chemical denotes antagonists http://purl.obolibrary.org/obo/CHEBI_48706

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T169 0-373 Sentence denotes The existence of several MasR subtypes has been suggested based on the differential capacity of the two MasR blockers to fully inhibit some biological actions of Ang-(1–7) [and perhaps of Ang (1–5), see Figure 1] [39,70]; therefore, differently from ACE2 enzymatic inhibitors, MasR antagonists should be administered in combinations, in order to inhibit ACE2 hyperactivity.

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T60 359-372 Phenotype denotes hyperactivity http://purl.obolibrary.org/obo/HP_0000752

2_test

Id Subject Object Predicate Lexical cue
32708755-23488800-20678750 217-219 23488800 denotes 70